rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Alphatec Holdings, Inc.

ATEC · Nasdaq

Health CareMedical DevicesAbove a falling average

ATEC stood above a rising 150-day average in 13 of the last 52 weekly readings, and has been out of that trend for the last 39 weeks. It is 8.5% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 39
Industry in uptrend
27% -7 in 4 wk
Insider buys, 12 months
$4.0M
Insider sales, 12 months
$108.2M
Officials’ trades on record
0
Institutions holding
257 (-11)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 13 of 52 weeks.

20 Apr – 19 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$47.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months42
Buyers · sellers2 · 13
WhoDidSharesTraded
Patrick MilesCEObought115,000at $8.8110 Sep 2026filed 10 Sep 2026
Tyson Eliot MarshallGENERAL COUNSEL & CORP. SEC.sold8,168at $9.655 Aug 2026filed 7 Aug 2026
Karen K. McGinnisDirectorsold6,050at $8.0111 Jun 2026filed 12 Jun 2026
Keith ValentineDirectorbought35,000at $7.0011 May 2026filed 11 May 2026
Keith ValentineDirectorbought43,847at $7.548 May 2026filed 11 May 2026
Keith ValentineDirectorbought56,153at $7.497 May 2026filed 11 May 2026
John Todd KoningCHIEF FINANCIAL OFFICERsold79,789at $12.3613 Mar 2026filed 17 Mar 2026
Scott LishCHIEF OPERATING OFFICERsold260,535at $12.3013 Mar 2026filed 17 Mar 2026
David SponselEVP, SALESsold163,452at $12.5211 Mar 2026filed 13 Mar 2026
Craig E. HunsakerEVP, PEOPLE & CULTUREsold82,765at $12.459 Mar 2026filed 10 Mar 2026
Craig E. HunsakerEVP, PEOPLE & CULTUREsold33,602at $12.226 Mar 2026filed 10 Mar 2026
Tyson Eliot MarshallGENERAL COUNSEL & CORP. SEC.sold88,835at $12.495 Mar 2026filed 9 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders257-11 on the quarter
New · exited42 · 55
Reported value$969.1M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202611,326,677$98.0M+1,238,495+12.3%
BRAIDWELL LPadded · filed 14 Aug 20266,531,439$56.5M+4,358,714+200.6%
AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 20266,521,659$56.4M+96,882+1.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20265,122,681$44.3M+208,902+4.3%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.reduced · filed 13 Aug 20263,536,538$30.6M-79,792−2.2%
STATE STREET CORPadded · filed 7 Aug 20263,481,349$30.1M+450,185+14.9%
JACOBS LEVY EQUITY MANAGEMENT, INCnew · filed 14 Aug 20263,352,133$29.0M+3,352,133
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20263,188,894$27.6M+282,472+9.7%
ROYAL BANK OF CANADAreduced · filed 14 Aug 20262,995,410$25.9M-1,521,182−33.7%
Nuveen, LLCreduced · filed 11 Aug 20262,601,600$22.5M-247,813−8.7%
31 Mar 2023 – 30 Jun 2026
159212265Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Thomas Andrew Carls Company insiderEVP, Data & Imaging Solutions · last 5 Oct 20260 · 0
Patrick Miles Company insiderCEO · last 10 Sep 20263 · 35
Tyson Eliot Marshall Company insiderGENERAL COUNSEL & CORP. SEC. · last 5 Aug 20260 · 10
Karen K. McGinnis Company insiderDirector · last 11 Jun 20260 · 3
David M. Demski Company insiderDirector · last 10 Jun 20263 · 1
David R. Pelizzon Company insiderDirector · last 10 Jun 20269 · 5
Keith Valentine Company insiderDirector · last 10 Jun 20264 · 0
Mortimer Berkowitz III Company insiderDirector · last 10 Jun 20267 · 3
Quentin S. Blackford Company insiderDirector · last 10 Jun 20261 · 0
John Todd Koning Company insiderCHIEF FINANCIAL OFFICER · last 13 Mar 20261 · 8
Scott Lish Company insiderCHIEF OPERATING OFFICER · last 13 Mar 20260 · 29
David Sponsel Company insiderEVP, SALES · last 11 Mar 20261 · 30

Same industry

RCEL Avita MedicalLeading+100%
HAE HaemoneticsLeading+48%
ATRC AtriCureLeading+47%
HTFL HeartflowLeading+47%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202569.6%
Operating profit marginFY 2025 · to 31 Dec 2025-10.7%
Free cash flow marginFY 2025 · to 31 Dec 20250.4%
Return on capital employedFY 2025 · to 31 Dec 2025-14.4%
Interest coverFY 2025 · to 31 Dec 2025-1.79×
Share count trendFY 2025 · to 17 Feb 20260.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$160.8M
Free cash flowFY 2025 · to 31 Dec 2025$2.8M

Analyst forecasts

No analyst forecasts yet.